228 related articles for article (PubMed ID: 15180106)
21. Effectiveness of a publicly funded pneumococcal vaccination program against invasive pneumococcal disease among the elderly in Victoria, Australia.
Andrews RM; Counahan ML; Hogg GG; McIntyre PB
Vaccine; 2004 Nov; 23(2):132-8. PubMed ID: 15531029
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive disease and hospital-treated pneumonia among people aged ≥65 years: a retrospective case-control study.
Leventer-Roberts M; Feldman BS; Brufman I; Cohen-Stavi CJ; Hoshen M; Balicer RD
Clin Infect Dis; 2015 May; 60(10):1472-80. PubMed ID: 25669354
[TBL] [Abstract][Full Text] [Related]
23. Pneumococcal Disease and the Effectiveness of the PPV23 Vaccine in Adults: A Two-Stage Bayesian Meta-Analysis of Observational and RCT Reports.
Latifi-Navid H; Latifi-Navid S; Mostafaiy B; Jamalkandi SA; Ahmadi A
Sci Rep; 2018 Jul; 8(1):11051. PubMed ID: 30038423
[TBL] [Abstract][Full Text] [Related]
24. Pneumococcal Vaccination in High-Risk Individuals: Are We Doing It Right?
Papadatou I; Spoulou V
Clin Vaccine Immunol; 2016 May; 23(5):388-395. PubMed ID: 27009210
[TBL] [Abstract][Full Text] [Related]
25. [Prevention of Streptococcus pneumoniae (pneumococcal) infections in adults].
Ludwig E; Mészner Z;
Orv Hetil; 2014 Dec; 155(50):1996-2004. PubMed ID: 25481502
[TBL] [Abstract][Full Text] [Related]
26. Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: a matched case-control study.
Vila-Corcoles A; Salsench E; Rodriguez-Blanco T; Ochoa-Gondar O; de Diego C; Valdivieso A; Hospital I; Gomez-Bertomeu F; Raga X
Vaccine; 2009 Mar; 27(10):1504-10. PubMed ID: 19171174
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of 23-valent pneumococcal polysaccharide vaccine and seasonal influenza vaccine for pneumonia among the elderly - Selection of controls in a case-control study.
Kondo K; Suzuki K; Washio M; Ohfuji S; Fukushima W; Maeda A; Hirota Y;
Vaccine; 2017 Aug; 35(36):4806-4810. PubMed ID: 28818473
[TBL] [Abstract][Full Text] [Related]
28. Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience.
Baldo V; Cocchio S; Gallo T; Furlan P; Romor P; Bertoncello C; Buja A; Baldovin T
PLoS One; 2016; 11(11):e0166637. PubMed ID: 27846277
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence.
Mangtani P; Cutts F; Hall AJ
Lancet Infect Dis; 2003 Feb; 3(2):71-8. PubMed ID: 12560191
[TBL] [Abstract][Full Text] [Related]
30. The effectiveness of pneumococcal polysaccharide vaccination in HIV-infected adults: a systematic review.
Pedersen RH; Lohse N; Østergaard L; Søgaard OS
HIV Med; 2011 Jul; 12(6):323-33. PubMed ID: 21059168
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial.
Lucero MG; Nohynek H; Williams G; Tallo V; Simões EA; Lupisan S; Sanvictores D; Forsyth S; Puumalainen T; Ugpo J; Lechago M; de Campo M; Abucejo-Ladesma E; Sombrero L; Nissinen A; Soininen A; Ruutu P; Riley I; Mäkelä HP
Pediatr Infect Dis J; 2009 Jun; 28(6):455-62. PubMed ID: 19483514
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.
Cutts FT; Zaman SM; Enwere G; Jaffar S; Levine OS; Okoko JB; Oluwalana C; Vaughan A; Obaro SK; Leach A; McAdam KP; Biney E; Saaka M; Onwuchekwa U; Yallop F; Pierce NF; Greenwood BM; Adegbola RA;
Lancet; 2005 Mar 26-Apr 1; 365(9465):1139-46. PubMed ID: 15794968
[TBL] [Abstract][Full Text] [Related]
33. [23-valent pneumococcal vaccine. Statement of the Consultive Committee of Immunizations on behalf of the Chilean Infectious Diseases Society: February 2010].
Ripoll M E; Valenzuela B MT; Vergara F R; Abarca V K; Muñoz M A; Jiménez de la Jara J; Pinto C ME; Luchsinger F V
Rev Chilena Infectol; 2010 Apr; 27(2):133-7. PubMed ID: 20556313
[TBL] [Abstract][Full Text] [Related]
34. Immunogenicity and safety of the 13-valent Pneumococcal Conjugate vaccine in 23-valent pneumococcal polysaccharide vaccine-naive and pre-immunized patients under treatment with chronic haemodialysis: a longitudinal quasi-experimental phase IV study.
Vandecasteele SJ; De Bacquer D; Caluwe R; Ombelet S; Van Vlem B
Clin Microbiol Infect; 2018 Jan; 24(1):65-71. PubMed ID: 28559003
[TBL] [Abstract][Full Text] [Related]
35. Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in patients with chronic pulmonary diseases: a matched case-control study.
Vila-Corcoles A; Ochoa-Gondar O; Rodriguez-Blanco T; Gutierrez-Perez A; Vila-Rovira A;
Hum Vaccin Immunother; 2012 May; 8(5):639-44. PubMed ID: 22634442
[TBL] [Abstract][Full Text] [Related]
36. 13-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults.
Plosker GL
Drugs; 2015 Sep; 75(13):1535-46. PubMed ID: 26242768
[TBL] [Abstract][Full Text] [Related]
37. Clinical effectiveness of pneumococcal polysaccharide vaccine in men: California Men's Health Study.
Hechter RC; Chao C; Jacobsen SJ; Slezak JM; Quinn VP; Van Den Eeden SK; Tseng HF
Vaccine; 2012 Aug; 30(38):5625-30. PubMed ID: 22789510
[TBL] [Abstract][Full Text] [Related]
38. Invasive pneumococcal disease in Catalonian elderly people, 2002-2009: serotype coverage for different anti-pneumococcal vaccine formulations at the beginning of the new conjugate vaccines era.
Vila-Corcoles A; Ochoa-Gondar O; Gomez-Bertomeu F; Raga-Luria X;
Vaccine; 2011 Oct; 29(43):7430-4. PubMed ID: 21803108
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness and Health Benefits of Pediatric 23-valent Pneumococcal Polysaccharide Vaccine, 7-valent Pneumococcal Conjugate Vaccine and Forecasting 13-valent Pneumococcal Conjugate Vaccine in China.
Mo X; Gai Tobe R; Liu X; Mori R
Pediatr Infect Dis J; 2016 Nov; 35(11):e353-e361. PubMed ID: 27753771
[TBL] [Abstract][Full Text] [Related]
40. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group.
Ortqvist A; Hedlund J; Burman LA; Elbel E; Höfer M; Leinonen M; Lindblad I; Sundelöf B; Kalin M
Lancet; 1998 Feb; 351(9100):399-403. PubMed ID: 9482293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
